|
Schlusskurs
Euronext Amsterdam
|
||
| - EUR | - |
|
| 14.09. | Pharming Group erhält US-FDA-Zulassung für Joenja bei seltener primärer Immundefizienz | MT |
| 11.09. | Pharming erhält FDA-Zulassung für Joenja als erste Behandlung für Kinder mit APDS in den USA | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.04% | +3.34% | -9.95% | +4.95% | +7.28% | +53.32% | +100.52% | +401.06% | +1’356.46% | 1’028 Mrd. | |
| -0.09% | +1.66% | -1.25% | +18.21% | +30.46% | +53.24% | +66.45% | +63.88% | +129.47% | 651 Mrd. | |
| -0.02% | +2.66% | -0.76% | +21.93% | +15.52% | +18.65% | +71.97% | +145.02% | +319.58% | 466 Mrd. | |
| -1.22% | +3.66% | -2.89% | +11.57% | +8.71% | +34.59% | +38.81% | +4.05% | +47.13% | 346 Mrd. | |
| -0.79% | +2.73% | -9.46% | -2.70% | +5.02% | +17.73% | +25.11% | +48.63% | +46.44% | 266 Mrd. | |
| +0.58% | +6.76% | +3.73% | -5.55% | -9.35% | +10.58% | +17.75% | +55.03% | +146.11% | 259 Mrd. | |
| +1.55% | +2.20% | -12.82% | +14.23% | +17.82% | +35.12% | +45.91% | +75.79% | +125.03% | 208 Mrd. | |
| +0.79% | +1.84% | -5.98% | -3.89% | -13.44% | -27.55% | -56.48% | -12.48% | +82.35% | 191 Mrd. | |
| -0.52% | +4.45% | +1.70% | +21.29% | +22.30% | +31.57% | +98.11% | +109.62% | +90.04% | 186 Mrd. | |
| +0.07% | -0.22% | -2.05% | +9.72% | +11.08% | +15.11% | -18.62% | -36.98% | -17.80% | 158 Mrd. | |
| +0.35% | -0.91% | -6.73% | +16.78% | +16.91% | +40.07% | +7.56% | +2.85% | +14.49% | 129 Mrd. | |
| -1.55% | -1.38% | -7.92% | +12.56% | +12.13% | +32.68% | +41.89% | +169.96% | +457.02% | 129 Mrd. | |
| -1.61% | +1.08% | -5.74% | -0.12% | -10.48% | -7.97% | -27.47% | -9.20% | +6.35% | 102 Mrd. | |
| -1.18% | +6.04% | -2.01% | -2.49% | +2.90% | +25.46% | +24.92% | +8.20% | -8.72% | 101 Mrd. | |
| +0.93% | +5.05% | -2.02% | -10.65% | -18.16% | -1.17% | +51.32% | +60.73% | +479.89% | 70.71 Mrd. | |
| +0.37% | +5.33% | +3.45% | +20.96% | +23.43% | +33.27% | +23.59% | +56.52% | +29.82% | 60.71 Mrd. | |
| -1.94% | -0.17% | -1.88% | +27.09% | +29.94% | +74.87% | -1.72% | +6.37% | -47.50% | 54.18 Mrd. | |
| -0.54% | +5.35% | +5.35% | +28.48% | +36.25% | +172.21% | +280.29% | +322.78% | -24.16% | 45.42 Mrd. | |
| +1.57% | +2.91% | -16.62% | -9.31% | -26.29% | -36.96% | -1.61% | -6.47% | +174.13% | 43.2 Mrd. | |
| Durchschnitt | -0.17% | +2.39% | -3.89% | +9.11% | +8.53% | +30.25% | +41.49% | +77.12% | +179.27% | 236.51 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -0.12% | +2.72% | -4.66% | +9.60% | +10.85% | +33.65% | +54.00% | +138.54% | +411.63% |
- Börse
- Aktien
- A1H65A Aktie
- Aktie
- Sektor PHARMING GROUP
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
